Related Experiment Video
Updated: May 31, 2025
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
[The impact of innate immune response on the efficacy of oncolytic viruses]
K N Trachuk1, N B Pestov1, Y K Biryukova1
1Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis).
Abstract:
Oncolytic viruses represent a promising class of immunotherapeutic agents for the treatment of malignant tumors. The proposed mechanism of action of various oncolytic viruses has initially been explained by the ability of such viruses to selectively lyse tumor cells without damaging healthy ones. Recently, there have emerged more studies determining the effect of the antiviral immunostimulating mechanisms on the effectiveness of treatment in cancer patients. Stimulation of innate immune cells by an oncolytic virus can initiate an adaptive antitumor immune response, yet at the same time, the antiviral mechanisms of the immune system can limit the spread of the virus, thereby reducing its effectiveness. Thus, the success of the clinical application of the oncolytic viruses directly depends on the three key components: tumor immunosuppression, antiviral responses, and antitumor immune responses. The review presents current data on the influence of pattern recognition receptors on the effectiveness of oncolytic viruses.
Insights
Oncolytic viruses are promising cancer treatments that kill tumor cells. Their effectiveness depends on tumor immunity, antiviral responses, and pattern recognition receptors.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Oncolytic viruses are a novel class of immunotherapeutics for cancer treatment.
- Their primary mechanism involves selective tumor cell lysis.
- Emerging research highlights the role of immune responses in their efficacy.
Purpose of the Study:
- To review the influence of pattern recognition receptors on oncolytic virus effectiveness.
- To explore the interplay between tumor immunosuppression, antiviral responses, and antitumor immunity.
Main Methods:
- Literature review of current data on oncolytic viruses and immune responses.
- Analysis of studies investigating pattern recognition receptors in oncolytic virotherapy.
Main Results:
- Oncolytic virus efficacy is modulated by both immune stimulation and limitation.
- Pattern recognition receptors play a crucial role in mediating these immune responses.
- Balancing antiviral and antitumor immunity is key for successful oncolytic virotherapy.
Conclusions:
- The effectiveness of oncolytic viruses is a complex interplay of viral oncolysis and host immune responses.
- Targeting pattern recognition receptors may enhance oncolytic virus therapy.
- Further research is needed to optimize oncolytic virus strategies by modulating immune components.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:27Tumor Immunotherapy
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:40Cell-mediated Immune Responses